Quick Takeaways
- GV 2019, L.P. filed SCHEDULE 13G/A for Prime Medicine, Inc. Common Stock, par value $0.00001 per share (PRME).
- Disclosed ownership: 12%.
- Date of event: 30 Sep 2025.
GV 2019, L.P. - 30 Sep 2025 SCHEDULE 13G/A Report for Prime Medicine, Inc. Common Stock, par value $0.00001 per share (PRME)
- Filing Manager
- GV 2019, L.P.
- Reporting Manager
- Alphabet Holdings LLC
- Symbol
- PRME
- Shares outstanding
- 134,654,455 shares
- Disclosed Ownership
- 16,562,498 shares
- Ownership
- 12%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 Nov 2025, 16:30:21 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"GV 2019, L.P. disclosed 12% ownership in Prime Medicine, Inc. Common Stock, par value $0.00001 per share (PRME) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Nov 2025, 16:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (12)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| GV 2019, L.P. | 7.5% | 10,100,058 | 0 | 10,100,058 | /s/ Inga Goldbard | Inga Goldbard/General Counsel of GV 2019 GP, L.L.C., the General Partner of GV 2019 GP, L.P., its General Partner | |
| GV 2019 GP, L.P. | 7.5% | 10,100,058 | 0 | 10,100,058 | /s/ Inga Goldbard | Inga Goldbard/General Counsel of GV 2019 GP, L.L.C., its General Partner | |
| GV 2019 GP, L.L.C. | 7.5% | 10,100,058 | 0 | 10,100,058 | /s/ Inga Goldbard | Inga Goldbard/General Counsel | |
| GV 2021, L.P. | 2.4% | 3,262,440 | 0 | 3,262,440 | /s/ Inga Goldbard | Inga Goldbard/General Counsel of GV 2021 GP, L.L.C., the General Partner of GV 2021 GP, L.P., its General Partner | |
| GV 2021 GP, L.P. | 2.4% | 3,262,440 | 0 | 3,262,440 | /s/ Inga Goldbard | Inga Goldbard/General Counsel of GV 2021 GP, L.L.C., its General Partner | |
| GV 2021 GP, L.L.C. | 2.4% | 3,262,440 | 0 | 3,262,440 | /s/ Inga Goldbard | Inga Goldbard/General Counsel | |
| GV 2023, L.P. | 2.4% | 3,200,000 | 0 | 3,200,000 | /s/ Inga Goldbard | Inga Goldbard/General Counsel of GV 2023 GP, L.L.C., the General Partner of GV 2023 GP, L.P., its General Partner | |
| GV 2023 GP, L.P. | 2.4% | 3,200,000 | 0 | 3,200,000 | /s/ Inga Goldbard | Inga Goldbard/General Counsel of GV 2023 GP, L.L.C., its General Partner | |
| GV 2023 GP, L.L.C. | 2.4% | 3,200,000 | 0 | 3,200,000 | /s/ Inga Goldbard | Inga Goldbard/General Counsel | |
| Alphabet Holdings LLC | 12% | 16,562,498 | 0 | 16,562,498 | /s/ Kathryn W. Hall | Kathryn W. Hall/Secretary | |
| XXVI Holdings Inc. | 12% | 16,562,498 | 0 | 16,562,498 | /s/ Kathryn W. Hall | Kathryn W. Hall/Assistant Secretary | |
| Alphabet Inc. | 12% | 16,562,498 | 0 | 16,562,498 | /s/ Kathryn W. Hall | Kathryn W. Hall/Assistant Secretary |